Surgalign Holdings, Inc. (SRGA): Price and Financial Metrics


Surgalign Holdings, Inc. (SRGA): $1.41

-0.07 (-4.73%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SRGA POWR Grades


  • SRGA scores best on the Value dimension, with a Value rank ahead of 80.69% of US stocks.
  • The strongest trend for SRGA is in Stability, which has been heading down over the past 31 weeks.
  • SRGA's current lowest rank is in the Stability metric (where it is better than 8.74% of US stocks).

SRGA Stock Summary

  • For SRGA, its debt to operating expenses ratio is greater than that reported by only 0.51% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Surgalign Holdings Inc's debt growth rate surpasses just 0% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for SRGA comes in at 96.62% -- higher than that of 97.8% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Surgalign Holdings Inc are EFOI, BBSI, TIG, AEZS, and PROS.
  • Visit SRGA's SEC page to see the company's official filings. To visit the company's web site, go to www.rtix.com.

SRGA Price Target

For more insight on analysts targets of SRGA, see our SRGA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.71 Average Broker Recommendation 1.36 (Strong Buy)

SRGA Stock Price Chart Interactive Chart >

Price chart for SRGA

SRGA Price/Volume Stats

Current price $1.41 52-week high $3.97
Prev. close $1.48 52-week low $1.41
Day low $1.41 Volume 8,508,100
Day high $1.49 Avg. volume 1,976,729
50-day MA $1.71 Dividend yield N/A
200-day MA $2.08 Market Cap 155.71M

Surgalign Holdings, Inc. (SRGA) Company Bio


Surgalign Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides medical technology solutions with focus on spine surgery and elevating clinical outcomes. Surgalign Holdings serves customers worldwide.


SRGA Latest News Stream


Event/Time News Detail
Loading, please wait...

SRGA Latest Social Stream


Loading social stream, please wait...

View Full SRGA Social Stream

Latest SRGA News From Around the Web

Below are the latest news stories about Surgalign Holdings Inc that investors may wish to consider to help them evaluate SRGA as an investment opportunity.

Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference

DEERFIELD, Ill., June 16, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will present at the Sidoti Virtual Investor Conference on Wednesday, June 23, 2021. The Company is scheduled to present at the conference at 2:30 p.m. Eastern Time the same day via webcast. A live audio webcast of the conference presentation will

Yahoo | June 16, 2021

Who Has Been Buying Surgalign Holdings, Inc. (NASDAQ:SRGA) Shares?

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also...

Yahoo | June 16, 2021

Surgalign Holdings, Inc. Announces Closing of $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

DEERFIELD, Ill., June 14, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (“Surgalign”) (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering for the issuance and sale of an aggregate of 28,985,508 shares of its common stock and warrants to purchase up to an aggregate of 28,985,508 shares of its common stock at a purchase pric

Yahoo | June 14, 2021

Surgalign Holdings, Inc. Announces $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

DEERFIELD, Ill., June 10, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (“Surgalign”) (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that it has entered into a definitive securities purchase agreement with several institutional investors for the issuance and sale of an aggregate of 28,985,508 shares of its common stock and warrants to purchase up to an aggregate of 28,985,508 shares of it

Yahoo | June 10, 2021

Surgalign announces collaboration with Inteneural Networks

Surgalign Holdings ([[SRGA]] +0.9%) and Inteneural Networks, a developer of innovative artificial intelligence has announced that they have entered into a strategic collaboration agreement.Under the agreement, Surgalign will gain access to Inteneural’s proprietary technology for evaluation of future integration within the Surgalign digital surgery portfolio. “The agreement between Surgalign and...

Seeking Alpha | June 7, 2021

Read More 'SRGA' Stories Here

SRGA Price Returns

1-mo -16.57%
3-mo -42.45%
6-mo -46.79%
1-year -55.66%
3-year -70.00%
5-year -62.30%
YTD -35.62%
2020 -20.07%
2019 -25.95%
2018 -9.76%
2017 26.15%
2016 -18.14%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7809 seconds.